Related references
Note: Only part of the references are listed.PCAF, ISX, and BRD4: a maleficent alliance serving lung cancer malignancy
Marc P. Stemmler
EMBO REPORTS (2020)
PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition
Li-Ting Wang et al.
EMBO REPORTS (2020)
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
Emily J. Faivre et al.
NATURE (2020)
BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK
Jordan S. Shafran et al.
MOLECULAR CANCER RESEARCH (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail
Zhong-yi Qin et al.
CANCER RESEARCH (2019)
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
Meghan A. Rice et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani et al.
FUTURE SCIENCE OA (2019)
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2019)
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)
Jonathan Welti et al.
CLINICAL CANCER RESEARCH (2018)
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
Guillaume P. Andrieu et al.
MOLECULAR CANCER RESEARCH (2018)
Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer
Lu Miao et al.
CANCER RESEARCH (2017)
Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival
L. Fan et al.
ONCOGENE (2016)
JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis
Na Li et al.
CANCER RESEARCH (2016)
BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
Guillaume Andrieu et al.
CANCER RESEARCH (2016)
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial- mesenchymal- transition in prostate cancer cell
Dong Li et al.
ONCOTARGET (2016)
Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer
Kathryn E. Ware et al.
ONCOTARGET (2016)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
Mechanisms navigating the TGF-β pathway in prostate cancer
Zheng Cao et al.
ASIAN JOURNAL OF UROLOGY (2015)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Epithelial plasticity in prostate cancer: principles and clinical perspectives
Rajdeep Das et al.
TRENDS IN MOLECULAR MEDICINE (2014)
BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
Anna C. Belkina et al.
JOURNAL OF IMMUNOLOGY (2013)
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
Lina Gao et al.
PLOS ONE (2013)
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer
Anastasia Wyce et al.
ONCOTARGET (2013)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelialmesenchymal transition and invasion in prostate cancer
Michael D. Amatangelo et al.
CARCINOGENESIS (2012)
Epithelial-mesenchymal transitions: insights from development
Jormay Lim et al.
DEVELOPMENT (2012)
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
Jan Budczies et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
The role of Snail in prostate cancer
Bethany N. Smith et al.
CELL ADHESION & MIGRATION (2012)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Snail and Slug Promote Epithelial-Mesenchymal Transition through β-Catenin-T-Cell Factor-4-dependent Expression of Transforming Growth Factor-β3
Damian Medici et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer
Karsten Gravdal et al.
CLINICAL CANCER RESEARCH (2007)
The identification of senescence-specific genes during the induction of senescence in prostate cancer cells
SR Schwarze et al.
NEOPLASIA (2005)
Share Paper
